Standout Papers

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensit... 1987 2026 2000 2013 3.5k
  1. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. (1987)
    James Carmichael, William DeGraff et al. PubMed
  2. Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers (2009)
    Peter C.C. Fong, David S. Boss et al. New England Journal of Medicine
  3. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (2010)
    M. William Audeh, James Carmichael et al. The Lancet
  4. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer (2012)
    Jonathan A. Ledermann, Philipp Harter et al. New England Journal of Medicine
  5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial (2010)
    Andrew Tutt, Mark E. Robson et al. The Lancet
  6. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study (2011)
    Karen A. Gelmon, Marc Tischkowitz et al. The Lancet Oncology
  7. Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval (2010)
    Peter C.C. Fong, Timothy A. Yap et al. Journal of Clinical Oncology
  8. Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer (1999)
    Joachim von Pawel, Joan H. Schiller et al. Journal of Clinical Oncology
  9. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. (1987)
    James Carmichael, William DeGraff et al. PubMed

Immediate Impact

12 by Nobel laureates 14 from Science/Nature 86 standout
Sub-graph 1 of 18

Citing Papers

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
A naturally inspired antibiotic to target multidrug-resistant pathogens
2022 StandoutNature
36 intermediate papers

Works of James Carmichael being referenced

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
1987 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
James Carmichael 10079 8491 2957 70 16.4k
Stan B. Kaye 9366 8573 2073 214 18.9k
Bryan T. Hennessy 8714 9505 1672 259 19.1k
Elizabeth A. Musgrove 6571 7328 2985 143 13.4k
Robert L. Sutherland 7679 10330 4946 236 18.9k
J. Dirk Iglehart 4788 5439 1874 138 10.6k
Joyce M. Slingerland 7967 10242 1268 119 15.3k
Robert I. Nicholson 9265 8004 4861 259 18.1k
Suzanne A.W. Fuqua 6289 9217 6537 201 16.3k
Michael J. Duffy 7872 8834 1065 260 18.6k
Robert F. Ozols 5376 5469 810 200 14.4k

All Works

Loading papers...

Rankless by CCL
2026